W.P. Purcell, G.E. Bass, and J.M. Clayton, Strategy of Drug Design: A Molecular Guide to Biological Activity, John Wiley and Sons, Inc., New York, 1973.
Chapters
• W.P. Purcell, "Application of Partition Coefficients, Electric Moments, Electronic Structures, and Regression Analyses to the Interpretation of Cholinesterase Inhibition," in Proceedings of the Conference on Structures and Reactions of DFP Sensitive Enzymes, edited by Edith Heilbronn, Swedish Research Institute of National Defense, Stockholm, 97-102, 1967.
• W.P. Purcell and J. M. Clayton, "Physicochemical Parameters in Drug Design," in Annual Reports in Medicinal Chemistry, 1968, edited by C.K. Cain, Academic Press, New York, 314-321, 1969
• W.P. Purcell, J.A. Singer, K. Sundaram, and G.L. Parks, "Quantitative Structure-Activity Relationships and Molecular Orbitals in Medicinal Chemistry," in Medicinal Chemistry, 3rd ed., edited by A. Burger, John Wiley and Sons, Inc., New York, Vol. 1, 196-192, 1970.
• J.M. Clayton, O.E. Millner, Jr., and W.P. Purcell, "Physicochemical Parameters in Drug Design," in Annual Reports in Medicinal Chemistry, 1969, edited by C.K. Cain, Academic Press, New York, 285-295, 1970.
• W.P. Purcell and J.M. Clayton, "Quantitative Structure-Activity Relationships and Molecular Orbitals in Medicinal Chemistry," in Molecular Orbital Studies in Chemical Pharmacology, edited by L. Kier, Springer-Verlag, New York, 1970.
• G.E. Bass, D.R. Hudson, J.E. Parker, and W.P. Purcell, "Interpretation of Antimalarial Activity in Terms of Regression Analyses, Molecular Orbital Calculations, and Theory of DNA-Drug Binding," in Progress in Molecular and Subcellular Biology, Springer-Verlag, Berlin, Germany, 126-133, 1971.
• J.M. Clayton and W.P. Purcell, "Physicochemical Approaches to Drug Design," in Drug Discovery, Science & Development in a Changing Society, Advances in Chemistry Series, No. 108, American Chemical Society, Washington, D.C., 123-140, 1971.
• J.C. Joyner and W.P. Purcell, "Quantum Pharmacology and Quantitative Structure-Activity Relationships: A Brief Review," in Proceedings of the Conference on Chemical Structure Biological Activity Relationships: Quantitative Approaches, Prague, Czechoslovakia, Akademiai Kiado Press, Budapest, Hungary, 13-23, 1973.
• W.P. Purcell, "Quantitative Structure-Activity Relationships: An Approach to Drug Design," in Molecular and Quantum Pharmacology, edited by E. Bergmann and B. Pullman, D. Reidel Publishing Company, Dordrecht, Holland, 37-41, 1974.
• W.P. Purcell, "Strategy of Drug Design," Drug Receptor Interactions in Antimicrobial Chemotherapy, Proceedings of the Sandoz Symposium, Springer-Verlag, Vienna, Austria, 15-24, 1974.
• W.P. Purcell and B. Testa, "The Development of Bioactive Compounds: A Multi-Disciplinary Approach," in Biological Activity and Chemical Structure, edited by W.Th. Nauta and R.F. Rekker, Elsevier Scientific Publishing Company, Amsterdam, 269-278, 1977.
• W.P. Purcell, "Quantitative Structure-Mutagenicity Relationships," in Structure-Activity Correlation as a Predictive Tool in Toxicology: Fundamentals, Methods, and Applications, edited by Leon Goldberg, Chemical Industry Institute of Toxicology Series, Hemisphere Publishing Corporation, New York, and McGraw-Hill International Book Company, 221-228, 1983.
• W.P. Purcell, "New Mathematical Approaches to QSAR," in Design of Bioactive Compounds, edited by M. Kuchar, J.R. Prous International, Section IV, 289-458, 1984.
